Sen. Bernie Sanders (I-VT) is planning to send a letter to Catalyst Pharmaceuticals on Monday asking why it is charging $375,000 annually for Firdapse. The treatment, which was available for free for years, is used to treat the rare neuromuscular disorder Lambert-Eaton Myasthenic Syndrome. (CNBC)

The newest members of the Medical Advertising Hall of Fame look back on careers well-spent. The latest inductees into the MAHF are CDM standout Carol DiSanto and agency entrepreneur Charlene Prounis. The pair has worked on drugs including Viagra and Rituxan and mentored the next generation of agency leaders. (MM&M)

Cancers prompted by obesity are on the rise among millennials and other young adults in the U.S. The report, published in The Lancet Public Health, found startling increases in six obesity-related cancers: colorectal, endometrial, gallbladder, kidney, pancreatic, and multiple myeloma. (CNN)

Experts from the International Agency for Research on Cancer at the World Health Organization said 57,000 cases of cervical cancer were diagnosed globally last year. The experts called for a vaccine that prevents cervical cancer to be swiftly distributed around the world. (Reuters)

Shares of Bristol-Myers Squibb jumped on Monday morning amid reports that Starboard Value had taken a stake in the drugmaker (CNBC). However, details were scarce about any plans the activist hedge fund might have for the pharmaceutical company. (Bloomberg)